Halozyme Therapeutics (HTI) Q3 2025 Earnings

Aug 5Confirmed
Q1 2025
Q2 2025
Q3 2025
0.96
1.15
1.35
1.54

Details

Expected EPS
1.268333
Actual EPS
1.54
Surprise EPS
0.27
Surprise Percent
+21.42%

Description

⁨Halozyme Therapeutics⁩ (⁦HTI⁩) has reported earnings of ⁦1.54⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts